NewEdge Wealth’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Hold |
91,463
| – | – | ﹤0.01% | 942 |
|
|
2025
Q1 | $126K | Hold |
91,463
| – | – | ﹤0.01% | 910 |
|
|
2024
Q4 | $278K | Hold |
91,463
| – | – | ﹤0.01% | 784 |
|
|
2024
Q3 | $455K | Hold |
91,463
| – | – | 0.01% | 640 |
|
|
2024
Q2 | $535K | Hold |
91,463
| – | – | 0.01% | 533 |
|
|
2024
Q1 | $791K | Hold |
91,463
| – | – | 0.02% | 462 |
|
|
2023
Q4 | $533K | Hold |
91,463
| – | – | 0.01% | 500 |
|
|
2023
Q3 | $234K | Hold |
91,463
| – | – | 0.01% | 584 |
|
|
2023
Q2 | $229K | Hold |
91,463
| – | – | 0.01% | 582 |
|
|
2023
Q1 | $192K | Hold |
91,463
| – | – | 0.01% | 585 |
|
|
2022
Q4 | $142K | Buy |
+91,463
| New | +$142K | 0.01% | 523 |
|